Article

Dilemma on Animal Models for Ocular Myasthenia Gravis: Can Lipoprotein Receptor-related Protein 4 Experimental Autoimmune Myasthenia Gravis Fix This Problem?

2025-02-24

Abstract excerpt

not-yet-known not-yet-known not-yet-known unknown Introduction: Myasthenia gravis (MG) is primarily caused by autoantibodies that have detrimental effects on neuromuscular junctions. There are two subtypes of MG, namely generalized MG (GMG) and ocular MG (OMG). Half of the patients with MG have OMG, and more than half of the patients with OMG could progress to having GMG in 2 years. Neurologists are mostly con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e3b0eb41-66f6-5248-8ca8-45274c19d0d8
DOI: 10.22541/au.174040402.20005040/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Dilemma on Animal Models for Ocular Myasthenia Gravis: Can Lipoprotein Receptor-related Protein 4 Experimental Autoimmune Myasthenia Gravis Fix This Problem?DOI 10.22541/au.174040402.20005040/v1Read

Pathogenesis of myasthenia gravis: update on disease types, models, and mechanismsSemantic proximity Read

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and OutcomesSemantic proximity Read

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read

The epidemiology of myasthenia gravis.Semantic proximity Read

Myasthenia gravis and related disorders: Pathology and molecular pathogenesisSemantic proximity Read

Complicating autoimmune diseases in myasthenia gravis: a review.Semantic proximity Read

Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia GravisSemantic proximity Read

Clinical Features and Prognosis of Ocular Myasthenia Gravis Patients with Different Phenotypes.Semantic proximity Read

Non-coding RNA and its network in the pathogenesis of Myasthenia GravisSemantic proximity Read

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read

The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A ReviewSemantic proximity Read